omniture
HISTOINDEX PTE. LTD

Latest News

qFIBS Demonstrates Suitability for Nonalcoholic Steatohepatitis (NASH) Assessment in Clinical Trials and Patient Care with Full Quantification of All Crucial Histopathological Features

SINGAPORE, Nov. 11, 2019 /PRNewswire/ -- qFIBS, a novel automated algorithm developed byHistoIndex ...

2019-11-11 13:28 478

Curiox Biosystems Achieves Commercialisation and Fund Raising Success in North Asia with the Support of Cornerstone Investor, ZIG Ventures

* CURIOX BIOSYSTEMS, is an A*STAR spinoff company, that develops bioinstrumentation solutions use...

2019-10-16 07:00 603

HistoIndex and ILBS Launch Centre of Excellence in New Delhi for Advanced Diagnostics and Clinical Research on Nonalcoholic Steatohepatitis (NASH)

SINGAPORE and NEW DELHI, Aug. 7, 2019 /PRNewswire/ -- In a cross border collaboration,HistoIndex

2019-08-07 16:30 1241

HistoIndex's Second Harmonic Generation (SHG) Technology: A Potentially Important Tool Used In Madrigal's Phase 2 Nonalcoholic Steatohepatitis (NASH) Clinical Trial

SINGAPORE, Dec. 24, 2018 /PRNewswire/ -- HistoIndex's AI-based SHG technology has the potential to ...

2018-12-24 08:28 1155

HistoIndex's Second Harmonic Generation (SHG) Technology: A Potentially Important Tool Used In Madrigal's Phase 2 Nonalcoholic Steatohepatitis (NASH) Clinical Trial

SINGAPORE, Dec. 23, 2018 /PRNewswire/ -- HistoIndex's AI-based SHG technology has the potential to ...

2018-12-23 17:00 583

HistoIndex Welcomes Its New CEO on Board

SINGAPORE, July 6, 2018 /PRNewswire/ -- HistoIndex ...

2018-07-06 06:00 853